BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17227633)

  • 1. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer.
    Liu CY; Wu CY; Lin JT; Lee YC; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S2-5. PubMed ID: 17227633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
    Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
    Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
    Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
    Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal history and family history as a predictor of gastric cardiac adenocarcinoma risk: a case-control study in Taiwan.
    Chen MJ; Wu DC; Ko YC; Chiou YY
    Am J Gastroenterol; 2004 Jul; 99(7):1250-7. PubMed ID: 15233662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between an insertion-deletion polymorphism in the pepsinogen C gene and gastric cancer as well as its precursors].
    Sun LP; Guo XL; Zhang Y; Chen W; Bai XL; Liu J; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3059-63. PubMed ID: 17288837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
    Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice.
    de Vries AC; Haringsma J; de Vries RA; ter Borg F; Nagtzaam NM; Steyerberg EW; van Dekken H; Kuipers EJ
    Gastrointest Endosc; 2009 Jul; 70(1):18-25. PubMed ID: 19249770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preneoplastic gastric lesions and helicobacter pylori in endoscopic detection and early diagnosis of gastric cancer in a population of a medium and high socio-economic level].
    Chacaltana A; Rodríguez C; Urday C; Ramon W; Espinoza J; Velarde H; Rodríguez I; Lucho E; Rauch E
    Rev Gastroenterol Peru; 2009; 29(3):218-25. PubMed ID: 19898593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.